{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T21:26:10Z","timestamp":1790717170526,"version":"4.1.0"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Pharm"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1007\/s11096-018-0661-5","type":"journal-article","created":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:49:40Z","timestamp":1527814180000},"page":"803-805","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Finasteride use during pregnancy and early neonatal outcome: a case report"],"prefix":"10.1007","volume":"40","author":[{"given":"Doua","family":"AlSaad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben H.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6058-3437","authenticated-orcid":false,"given":"Sawsan","family":"Al-Obaidly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,6,1]]},"reference":[{"key":"661_CR1","unstructured":"Finasteride. Food and Drug Administration (FDA). Jan 2014. Available at: http:\/\/www.fda.gov\/. Accessed 6th Dec 2017."},{"issue":"4","key":"661_CR2","doi-asserted-by":"publisher","first-page":"e9860","DOI":"10.5812\/ijem.9860","volume":"11","author":"I Herskovitz","year":"2013","unstructured":"Herskovitz I, Tosti A. Female pattern hair loss. Int J Endocrinol Metab. 2013;11(4):e9860.","journal-title":"Int J Endocrinol Metab"},{"issue":"7","key":"661_CR3","first-page":"56","volume":"9","author":"JM Hirshburg","year":"2016","unstructured":"Hirshburg JM, Kelsey PA, Therrien CA, Gavino AC, Reichenberg JS. Adverse effects and safety of 5-alpha reductase inhibitors (Finasteride, Dutasteride): a systematic review. J Clin Aesthet Dermatol. 2016;9(7):56\u201362.","journal-title":"J Clin Aesthet Dermatol"},{"issue":"1","key":"661_CR4","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1002\/tera.1420420111","volume":"42","author":"RL Clark","year":"1990","unstructured":"Clark RL, Antonello JM, Grossman SJ, Wise LD, Anderson C, Bagdon WJ, et al. External genitalia abnormalities in male rats exposed in utero to finasteride, a 5 alpha-reductase inhibitor. Teratology. 1990;42(1):91\u2013100.","journal-title":"Teratology"},{"key":"661_CR5","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1093\/toxsci\/kfg128","volume":"74","author":"CJ Bowman","year":"2003","unstructured":"Bowman CJ, Barlow NJ, Turner KJ, Wallace DG, Foster PM. Effects of in utero exposure to finasteride on androgen-dependent reproductive development in the male rat. Toxicol Sci. 2003;74:393\u2013406.","journal-title":"Toxicol Sci"},{"issue":"2","key":"661_CR6","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1002\/(SICI)1096-9926(199702)55:2<119::AID-TERA1>3.0.CO;2-Z","volume":"55","author":"S Prahalada","year":"1997","unstructured":"Prahalada S, Tarantal AF, Harris GS, Ellsworth KP, Clarke AP, Skiles GL, et al. Effects of finasteride, a type 2 5-alpha reductase inhibitor, on fetal development in the rhesus monkey (Macaca mulatta). Teratology. 1997;55(2):119\u201331.","journal-title":"Teratology"},{"key":"661_CR7","first-page":"2469","volume":"47","author":"M Pole","year":"2001","unstructured":"Pole M, Koren G. Finasteride. Does it affect spermatogenesis and pregnancy? Can Fam Physician. 2001;47:2469\u201370.","journal-title":"Can Fam Physician"},{"key":"661_CR8","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.2164\/jandrol.109.009381","volume":"31","author":"E Laborde","year":"2010","unstructured":"Laborde E, Brannigan E. Effect of 1-mg Dose of Finasteride on Spermatogenesis and Pregnancy. J Androl. 2010;31:e1\u20132.","journal-title":"J Androl"},{"issue":"2","key":"661_CR9","first-page":"248","volume":"5","author":"KH Ahn","year":"2015","unstructured":"Ahn KH, Shin J, Hong SC, Han JY, Lee EH, Lee JS, et al. Pregnancy outcomes with paternal exposure to finasteride, a synthetic 5-alpha-reductase inhibitor: a case series. J Clin Toxicol. 2015;5(2):248.","journal-title":"J Clin Toxicol"},{"key":"661_CR10","unstructured":"Overview of off-label use of 5-apha reductase inhibitors in women. Netherland pharmacovigilance center lareb. Apr 2015. Available at: http:\/\/www.lareb.nl\/?lang=en-GB. Accessed 6th Dec 2017."},{"issue":"2","key":"661_CR11","doi-asserted-by":"publisher","first-page":"155","DOI":"10.4103\/0256-4947.51805","volume":"29","author":"BI Sallout","year":"2009","unstructured":"Sallout BI, Al Wadi KA. Aphalangia possibly linked to unintended use of finasteride during early pregnancy. Ann Saudi Med. 2009;29(2):155.","journal-title":"Ann Saudi Med"}],"container-title":["International Journal of Clinical Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11096-018-0661-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-018-0661-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-018-0661-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,18]],"date-time":"2021-02-18T00:42:13Z","timestamp":1613608933000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11096-018-0661-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,1]]},"references-count":11,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["661"],"URL":"https:\/\/doi.org\/10.1007\/s11096-018-0661-5","relation":{},"ISSN":["2210-7703","2210-7711"],"issn-type":[{"value":"2210-7703","type":"print"},{"value":"2210-7711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,1]]},"assertion":[{"value":"1 June 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Authors declare no conflict with interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}